“Long-term impact of elexacaftor/tezacaftor/ivacaftor on small and large airways in people with cystic fibrosis aged ≥6 years: 24-month real-world evidence from the German Cystic Fibrosis Registry” Stefanie Dillenhöfer, Katharina Schütz, Manuel Burkhart, Helmut Ellemunter, Matthias Kappler, Sarah Sieber, Lutz Naehrlich, Folke Brinkmann and Sivagurunathan Sutharsan on behalf of the German CF Registry of the Mukoviszidose e.V. and participating cystic fibrosis sites. ERJ Open Res 2026; 12: 00813-2025.

ERJ Open Research · Published 2026-07-01 · DOI 10.1183/23120541.50813-2025

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1183/23120541.50813-2025

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Lung microenvironment proteomics identifies immune protein expression in interstitial pneumonia with autoimmune features (IPAF) · ERJ Open Research · 2026 · Same journal
• Non-adherence to inhaled corticosteroids is associated with negative mepolizumab response · ERJ Open Research · 2026 · Same journal
• Telemedicine in COPD on home NIV - adherence and QOL in a randomized controlled trial · ERJ Open Research · 2026 · Same journal
• Voice as biomarker for early exacerbation detection in asthma and COPD: the TACTICAS study · ERJ Open Research · 2026 · Same journal
• Regnase-1 upregulation via antisense oligonucleotides alleviates pulmonary hypertension · ERJ Open Research · 2026 · Same journal
• Improving paediatric asthma outcomes in rural settings: clinical effectiveness of a multi–component asthma care model · ERJ Open Research · 2026 · Same journal
• Clinical and Economic Effectiveness of Telehealth in Home Mechanical Ventilation · ERJ Open Research · 2026 · Same journal
• Air pollution and pathogen-specific acute exacerbations of COPD · ERJ Open Research · 2026 · Same journal
• Race-neutral GLI-2022 equations alter COPD trial eligibility in a northeast Asian COPD cohort · ERJ Open Research · 2026 · Same journal
• Bosutinib-associated pulmonary arterial hypertension without prior dasatinib exposure · ERJ Open Research · 2026 · Same journal